Kevin Bitterman retweetledi

Congratulations to the team @MarianaOncology on their acquisition by Novartis for $1B upfront! Having co-founded, seeded, and incubated Mariana with Simon Read as an Atlas EIR, we are excited to follow the advancement of Mariana's drug candidates within @Novartis

English

















